**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 3460-18-2 |2,5-Dibromonitrobenzene | 97% | 222-404-8 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 20/21/22 36/37/38
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Irritating to eyes, respiratory system and skin.The toxicological
properties of this material have not been fully investigated.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation. Harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause gastrointestinal irritation with
nausea, vomiting and diarrhea. May cause cardiac disturbances. May
cause central nervous system depression.
Inhalation:
Causes respiratory tract irritation. The toxicological properties of
this substance have not been fully investigated. May cause cardiac
abnormalities. Inhalation at high concentrations may cause CNS
depression and asphixiation. Harmful if inhaled.
Chronic:
There is a danger of cumulative effects.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If breathing
is difficult, give oxygen. Get medical aid. Do NOT use mouth-to-mouth
resuscitation. If breathing has ceased apply artificial respiration
using oxygen and a suitable mechanical device such as a bag and a
mask.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Containers
may explode when heated.
Extinguishing Media:
Use water spray to cool fire-exposed containers. Use water spray,
dry chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Minimize dust generation and
accumulation. Avoid contact with eyes, skin, and clothing. Keep
container tightly closed. Avoid ingestion and inhalation. Use with
adequate ventilation. Wash clothing before reuse.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 3460-18-2:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Crystalline powder
Color: yellow
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 81.00 - 85.00 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: 2.3740g/cm3
Molecular Formula: C6H3Br2NO2
Molecular Weight: 280.89
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat.
Incompatibilities with Other Materials:
Oxidizing agents, strong bases.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide, hydrogen bromide.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 3460-18-2 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
2,5-Dibromonitrobenzene -
Not listed by ACGIH, IARC, or NTP.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 2811
Packing Group: II
IMO
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing Group: II
RID/ADR
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing group: II
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 22 Do not breathe dust.
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 3460-18-2: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 3460-18-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 3460-18-2 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #6 Date: 2/23/2005
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
2-Methylcyclopropanecarboxylic Acid, 98%
| 29555-02-0 |
|
m-Phenylene diisocyanate
| 123-61-5 |
|
2-Dodecanol, 99%
| 10203-28-8 |
|
Oxalic Acid Bis(Benzylidenehydrazide), 97% (UV-Vis)
| 6629-10-3 |
|
5-Bromopyrimidine, 98%
| 4595-59-9 |
|
4,6-Diamino-2-Mercaptopyrimidine, Hemihydrate, 99%
| 1004-39-3 |
|
4-(4'-Aminophenylazo)-Phenylarsonic Acid
| 6966-64-9 |
|
2,4-Dicyano-3-Methylglutaramide, 99%
| 5447-66-5 |
|
Ethyl trimethylacetate, 98%
| 3938-95-2 |
|
2-Mercapto-4-methylpyrimidine hydrochloride, 99%
| 6959-66-6 |
|
1-Pyrrolidinecarboxaldehyde, 97%
| 3760-54-1 |
|
n-Methyleneglycinonitrile (trimer)
| 6865-92-5 |
|
5-Methoxytryptamine hydrochloride, 97%
| 66-83-1 |
|
Nifuroxime
| 555-15-7 |
|
N-Alpha-Acetyl-L-Histidine Monohydrate 99+%
| 39145-52-3 |
|
11-Bromoundecanoic acid, tech., 93%
| 2834-05-1 |
|
Tert.-Butyl Disulfide, 98%
| 110-06-5 |
|
4'-Dodecyloxyacetophenone, 94% (GC)
| 2175-80-6 |
|
Ethylmagnesium chloride, 25 wt% solution in tetrahydrofuran
| 109-99-9 |
|
Methyl Vinyl Ether/Maleic Acid Copolymer, Low Molecular Weight
| 25153-40-6 |
|
Chlorohydroquinone, tech., 90%
| 615-67-8 |
|
Tri-n-octylphosphine oxide, 97%
| 78-50-2 |
|
Silver proteinate (mild)
| 9008-42-8 |
|
Lead (IV) Oxide, P.A.
| 1309-60-0 |
|
1,4-Butane Sultone, 99+%
| 1633-83-6 |
|
4-Chloro-3-Iodobenzotrifluoride, 99%
| 672-57-1 |
|
Theophylline, Anhydrous, U.S.P./N.F.
| 58-55-9 |
|
P-Anisoyl Chloride, 99%
| 100-07-2 |
|
3-Carboxy-1,4-dimethyl-1h-pyrrole-2-acetic acid
| 33369-45-8 |
|
4-Amino-2,6-dichlorophenol, 98%
| 5930-28-9 |
|
Aminoguanidine Hemisulfate
| 996-19-0 |
|
N-Methylmorpholine hydrochloride, 99+%
| 3651-67-0 |
|
2-Chloro-4,6-dimethoxy-1,3,5-triazine, 98%
| 3140-73-6 |
|
1-Heptyne, 99%
| 628-71-7 |
|
(R)-(+)-2,2'-Bis(diphenylphosphino)- 1,1'-binaphthyl, 99+%
| 76189-55-4 |
|
2-Propene-1-Sulfonic Acid Sodium Salt (Pract)
| 2495-39-8 |
|
6-Amino-1-Hexanol, 94%
| 4048-33-3 |
|
2,5-Dibromonitrobenzene, 97%
| 3460-18-2 |
|
Rubidium Fluoride Hydrate, 99+%
| 16422-67-6 |
|
7-Chloro-2H-1,4-Benzothiazin-3(4H)-One,99%
| 5333-05-1 |
|
2-Methyl-2-Nitropropane, 99%
| 594-70-7 |
|
N-Ethyl-n-butylamine, 99%
| 13360-63-9 |
|
2,6-Dimethylaniline, 99%
| 87-62-7 |
|
2-Chloro-3-Methylquinoline, 97%
| 57876-69-4 |
|
3-Cyanobenzaldehyde, 99%
| 24964-64-5 |
|
N,N'-Diallyltartardiamide, 99+%
| 28843-34-7 |
|
3-Aminobenzonitrile, 99%
| 2237-30-1 |
|
2-Chloropyridine-n-oxide hydrochloride, 97%
| 20295-64-1 |
|
Sodium perchlorate
| 7601-89-0 |
|
Butadiene sulfone, 98%
| 77-79-2 |
|
|